ALX Oncology Holdings ALXO

$ 1.28 5.79%

Quarterly report 2024-Q3
added 11-07-2024

ALX Oncology Holdings Balance Sheet 2011-2024 | ALXO

Annual Balance Sheet ALX Oncology Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-11.9 M	-38.7 M	-	-	-3.6 M	-8.26 M	-	-	-	-	-	-	-
Long Term Debt	9.64 M	9.39 M	-	-	5.42 M	-	-	-	-	-	-	-	-
Long Term Debt Current	847 K	755 K	313 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	5.97 M	136 K	-	-	-	-	-	-	-
Total Current Liabilities	36 M	28.3 M	15.3 M	6.2 M	-	-	-	-	-	-	-	-	-
Total Liabilities	52.8 M	43 M	17.1 M	6.21 M	11 M	2.01 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-486 M	-325 M	-202 M	-119 M	-72.8 M	-53.5 M	-	-	-	-	-	-	-
Total Assets	243 M	306 M	380 M	436 M	10.7 M	11.2 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	22.4 M	48.8 M	364 M	434 M	9.02 M	8.26 M	-	-	-	-	-	-	-
Book Value	190 M	263 M	363 M	430 M	-276 K	9.16 M	-	-	-	-	-	-	-
Total Shareholders Equity	190 M	263 M	363 M	430 M	-70.6 M	-51.8 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet ALX Oncology Holdings

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	9.84 M	9.77 M	9.7 M	9.64 M	9.58 M	9.51 M	9.45 M	9.39 M	5.48 M	70 K	175 K	280 K	385 K	489 K	131 K	-	3.19 M	3.93 M	-	5.42 M	5.42 M	5.42 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	48.9 M	55.3 M	48.5 M	52.8 M	51.4 M	33.2 M	37.8 M	43 M	30.7 M	29.7 M	20.1 M	17.1 M	14.6 M	16.3 M	14.4 M	6.21 M	6.21 M	6.21 M	6.21 M	11 M	11 M	11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-592 M	-561 M	-522 M	-486 M	-441 M	-390 M	-356 M	-325 M	-295 M	-259 M	-227 M	-202 M	-174 M	-149 M	-133 M	-119 M	-119 M	-119 M	-119 M	-72.8 M	-72.8 M	-72.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	186 M	215 M	213 M	243 M	220 M	246 M	278 M	306 M	318 M	346 M	364 M	380 M	400 M	421 M	433 M	436 M	436 M	436 M	436 M	10.7 M	10.7 M	10.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	16.1 M	15.5 M	14 M	22.4 M	19.6 M	38 M	63.2 M	48.8 M	49.1 M	66.4 M	159 M	364 M	385 M	410 M	430 M	434 M	434 M	434 M	434 M	9.02 M	9.02 M	9.02 M	-	8.26 M	-	-	-	22.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	137 M	159 M	164 M	190 M	169 M	213 M	240 M	263 M	287 M	316 M	344 M	363 M	385 M	405 M	418 M	430 M	430 M	430 M	430 M	-276 K	-276 K	-276 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	137 M	159 M	164 M	190 M	169 M	213 M	240 M	263 M	287 M	316 M	344 M	363 M	385 M	405 M	418 M	430 M	430 M	430 M	430 M	-70.6 M	-70.6 M	-70.6 M	-55.9 M	-51.8 M	-	-	-	-38.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency